Riskpilot← Back to searchSign inGet full accessAbbott Medical Danmark A/S
A/SActiveCVR 17558501Produktionsvej 14Wholesale of pharmaceutical and medical goods · NACE 4646Est. 199421 employees
Revenue 2024
DKK 192M
+3% vs 2023
EBITDA margin
3.8%
+6% vs 2023
Equity ratio
74.7%
Financial strength
Net profit 2024
DKK 7,9M
+12% vs 2023
| Revenue | DKK 192M | +3% |
| EBITDA | DKK 7,3M | +6% |
| Net profit | DKK 7,9M | +12% |
| Total assets | DKK 187,6M | +6% |
| Equity | DKK 140,1M | +6% |
| Employees | 21 | — |
Legal name
Abbott Medical Danmark A/S
CVR number
17558501
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. januar 1994
Share capital
DKK 1.000.000
Employees
21 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af bestyrelsesformanden alene eller af den samlede bestyrelse
Company purpose
Selskabets formål er at købe, sælge, handle (hvad enten som agent eller andet), eksportere, importere, vedligeholde, inspicere, afprøve, montere og fremstille medicinske og farmaceutiske produkter samt udvikle, producere og markedsføre teknologi i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser eller assistance, herunder af administrativ, driftsmæssig, finansiel, videnskabelig eller industriel karakter, i tilknytning til selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selskaber.
Address
Produktionsvej 14
Phone
+4544947541
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 213.955 | 239.642 | 188.118 | 185.831 | 191.993 |
| Staff expenses | -23.735 | -25.309 | -26.157 | -24.888 | -28.238 |
| EBITDA | 8.433 | 8.059 | 6.405 | 6.886 | 7.311 |
| Depreciation & amort. | -942 | -954 | -1.153 | -1.311 | -1.767 |
| EBIT | 7.491 | 7.104 | 5.252 | 5.575 | 5.544 |
| Net financials | -350 | -198 | 138 | 3.917 | 4.824 |
| Profit before tax | 7.141 | 6.907 | 5.390 | 9.493 | 10.367 |
| Tax | 1.875 | 1.674 | 1.340 | 2.433 | 2.470 |
| Net profit | 5.265 | 5.233 | 4.050 | 7.060 | 7.898 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 160.707 | 186.301 | 173.655 | 177.093 | 187.554 |
| Equity | 115.861 | 121.094 | 125.144 | 132.204 | 140.101 |
| Long-term debt | 0 | 0 | 0 | 0 | -315 |
| Short-term debt | 44.846 | 65.207 | 48.511 | 44.890 | 47.453 |
| Total debt | 44.846 | 65.207 | 48.511 | 44.890 | 47.453 |
EBITDA margin
3.8%
This company
15.8%
Market median
-76% vs market
20202024
Equity ratio
74.7%
This company
38.2%
Market median
+96% vs market
20202024
Return on equity
5.6%
This company
18.4%
Market median
-70% vs market
20202024
Net profit margin
4.1%
This company
8.1%
Market median
-49% vs market
20202024
Asset turnover
1.02×
This company
1.12×
Market median
+9% vs market
20202024
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
TJ Founder | Founder | 1994 |
HH Founder | Founder | 1994 |
MG Founder | Founder | 1994 |
MT Management | Management | 2024 |
| Former (4) | ||
CA Management | Management | 1994 – 1997 |
UA Management | Management | 2003 – 2007 |
SE Management | Management | 1997 – 2003 |
FW Management | Management | 2007 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2017 | |
| Chairman | 2022 | |
| Former (11) | ||
| Chairman | 2011 – 2016 | |
| Board of Directors | 2012 – 2017 | |
| Chairman | 1997 – 2006 | |
| Chairman | 1994 – 1995 | |
| Board of Directors | 2007 – 2012 | |
| Chairman | 1995 – 1997 | |
| Chairman | 2016 – 2017 | |
| Chairman | 2006 – 2011 | |
| Board of Directors | 1994 – 2007 | |
| Chairman | 2019 – 2022 | |
| Chairman | 2017 – 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2018 | |
| Individual | 100% | 100% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ABBOTT LABORATORIES A/S
Abbott Medical Danmark A/S Board members of Abbott Medical Danmark A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claude Arthur Marie Van Droogenbroeck | Management | 0 companies |
| Tyge Jesper Rothe | Founder | 0 companies |
| Ulf Arendt Bertilsson Grape | Management | 0 companies |
| Svend Erik Volfram Hansen | Management | 0 companies |
| Henning Hansen | Founder | 0 companies |
| Mogens Gaarden | Founder | 0 companies |
| Mika Tapio Mustonen | Management | 0 companies |
| Flemming Wærn Johannessen | Management | 0 companies |
| Jason Ashley Zellers | Chairman | 0 companies |
| Dodd Joseph Gray | Board of Directors | 0 companies |
| Kevin O'Malley | Chairman | 0 companies |
| Todd Frederik Davenport | Chairman | 0 companies |
| Willem Jozef Jean Eeraerts | Board of Directors | 0 companies |
| Diane Marion Johnson | Chairman | 0 companies |
| Kashif Rashid | Chairman | 0 companies |
| Fredrik Björn Anders Björnulfson | Board of Directors | 0 companies |
| Pamela Sue Krop | Chairman | 0 companies |
| Bradley Jay Slater | Chairman | 0 companies |
| Michel Victor Hestor Cavadini | Board of Directors | 0 companies |
| Benjamin Edward Oosterbaan | Chairman | 0 companies |
| Brian B. Yoor | Chairman | 0 companies |